Your session is about to expire
← Back to Search
Diabetes Prevention Program for Diabetes (SMSC Trial)
N/A
Waitlist Available
Led By Kaimi A Sinclair, PhD, MPH
Research Sponsored by Washington State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
SMSC Trial Summary
This trial aims to create lifestyle interventions that reduce diabetes risk in minority groups.
SMSC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline weight
Secondary outcome measures
Change in dietary habits and consumption and frequency of physical activity
Changes in Stages of Change for healthy eating and physical activity
SMSC Trial Design
2Treatment groups
Experimental Treatment
Group I: Diabetes InterventionExperimental Treatment1 Intervention
Diabetes Prevention Program
Group II: Delayed InterventionExperimental Treatment1 Intervention
Diabetes Prevention Program
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diabetes Prevention Program
2018
Completed Phase 2
~890
Find a Location
Who is running the clinical trial?
Washington State UniversityLead Sponsor
101 Previous Clinical Trials
56,457 Total Patients Enrolled
2 Trials studying Diabetes
116 Patients Enrolled for Diabetes
Kaimi A Sinclair, PhD, MPHPrincipal InvestigatorWashington State University
1 Previous Clinical Trials
100 Total Patients Enrolled
1 Trials studying Diabetes
100 Patients Enrolled for Diabetes
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger